Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Text Size

Resistance Training in Elderly

This study has been completed.
Sponsor:
Collaborators:
The Anna Foundation
DSM Food Specialties
Information provided by:
Maastricht University Medical Center
ClinicalTrials.gov Identifier:
NCT00744094
First received: August 28, 2008
Last updated: September 22, 2015
Last verified: August 2008
History of Changes
  Purpose
In the present study the investigators aim to determine whether protein supplementation can augment the response to a 12 week resistance training program in healthy elderly men.

Condition Intervention Phase
Sarcopenia
Atrophy
Aging
 Dietary Supplement: protein drink
Behavioral: Resistance training
 Phase 1
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: The Influence of Resistance Training on Body Composition and Muscle Characteristics in Healthy Elderly

Further study details as provided by Maastricht University Medical Center:

Primary Outcome Measures:
  • Muscle mass measured at limb and cellular level [ Time Frame: before and after 12 weeks of intervention ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Muscle strength [ Time Frame: before and after 12 weeks of intervention ] [ Designated as safety issue: No ]
  • Body composition [ Time Frame: before and after 12 weeks of intervention ] [ Designated as safety issue: No ]
Enrollment: 26
Study Start Date: January 2007
Study Completion Date: July 2008
Primary Completion Date: September 2007 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Placebo Comparator: 1
placebo drink
 Behavioral: Resistance training
12 weeks resistance training, 3 days per week
Experimental: 2
protein drink
 Dietary Supplement: protein drink
250 ml protein hydrolysate solution
Behavioral: Resistance training
12 weeks resistance training, 3 days per week

  Eligibility
Ages Eligible for Study:   65 Years to 85 Years   (Adult, Senior)
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Living independently

Exclusion Criteria:

  • Diabetes
  • Cardiovascular disease
  • Orthopedic limitations
  • Any disorder known to compromise ability for resistance training
  • History of resistance training in past 5 years
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00744094

Locations
Netherlands
Maastricht University
Maastricht, Netherlands, 6200MD
Sponsors and Collaborators
Maastricht University Medical Center
The Anna Foundation
DSM Food Specialties
Investigators
Principal Investigator: Luc JC van Loon, PhD Maastricht University
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Responsible Party: Dr. L. van Loon, Maastricht University
ClinicalTrials.gov Identifier: NCT00744094     History of Changes
Other Study ID Numbers: MEC 06-3-062B 
Study First Received: August 28, 2008
Last Updated: September 22, 2015
Health Authority: Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)

Keywords provided by Maastricht University Medical Center:
resistance training
protein supplementation
hypertrophy

Additional relevant MeSH terms:
Atrophy
Sarcopenia
Pathological Conditions, Anatomical
Muscular Atrophy
 Neuromuscular Manifestations
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms

ClinicalTrials.gov processed this record on September 23, 2016